In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011

In Vitro Metabolic Studies of REV-ERB Agonists SR9009 and SR9011

SR9009 and SR9011 are attractive as performance-enhancing substances due to their REV-ERB agonist effects and thus circadian rhythm modulation activity. Although no pharmaceutical preparations are available yet, illicit use of SR9009 and SR9011 for doping purposes can be anticipated, especially sinc...

Full description

Bibliographic Details
Main Authors: Lore Geldof, Koen Deventer, Kris Roels, Eva Tudela, Peter Van Eeno
Format: Article
Language:English
Published: MDPI AG 2016-10-01
Series:International Journal of Molecular Sciences
Subjects:
REV-ERB agonists
SR9009
SR9011
phase I metabolism
in vitro studies
liquid chromatography–high resolution mass spectrometry (LC–HRMS)
doping agents
Online Access:http://www.mdpi.com/1422-0067/17/10/1676

Internet

http://www.mdpi.com/1422-0067/17/10/1676

Similar Items